Elsa Poullot
Overview
Explore the profile of Elsa Poullot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phina-Ziebin X, Bachy E, Gros F, Di Blasi R, Herbaux C, Bay J, et al.
Blood Adv
. 2025 Jan;
PMID: 39874518
High-grade-B-cell lymphoma (HGBL) with MYC and BCL2 and/or BCL6 rearrangements (double hit [HGBL-DH] or triple hit [HGBL-TH]), or not otherwise specified (HGBL-NOS), are considered to be more aggressive diseases among...
2.
Petronilho S, Poullot E, Andre A, Robe C, Nouhoum S, Fataccioli V, et al.
Am J Surg Pathol
. 2025 Jan;
49(3):273-283.
PMID: 39758028
Lymphomas of T-follicular helper origin (T-follicular helper-cell lymphoma [TFHL]) are often accompanied by an expansion of B-immunoblasts, occasionally with Hodgkin/Reed-Sternberg-like (HRS-like) cells, making the differential diagnosis with classic Hodgkin lymphoma...
3.
Fraix A, Itti E, Zaroui A, Kharoubi M, Poullot E, Lerman L, et al.
Orphanet J Rare Dis
. 2024 Oct;
19(1):381.
PMID: 39407234
Background: Bone scintigraphy (BS) is established as an accurate, non-invasive method for the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). In a real-life setting, however, some patients with no cardiac uptake...
4.
Bezard M, Zaroui A, Kharoubi M, Lam F, Poullot E, Teiger E, et al.
Amyloid
. 2024 Jul;
31(3):209-219.
PMID: 38973117
Background: Cardiac involvement in systemic light chain amyloidosis (AL) leads to chronic heart failure and is a major prognosis factor. Severe cellular defects are provoked in cardiac cells by tissue-deposited...
5.
Annabi M, Carter-Storch R, Zaroui A, Galat A, Oghina S, Kharoubi M, et al.
J Am Heart Assoc
. 2024 Jun;
13(13):e034723.
PMID: 38904242
Background: Cardiac amyloidosis (CA) is frequently found in older patients with aortic stenosis (AS). However, the prevalence of AS among patients with CA is unknown. The objective was to study...
6.
Baron M, Labreche K, Veyri M, Desire N, Bouzidi A, Seck-Thiam F, et al.
Haematologica
. 2024 Jun;
109(11):3615-3630.
PMID: 38841782
Non-Hodgkin lymphomas (NHL) commonly occur in immunodeficient patients, both those infected by human immunodeficiency virus (HIV) and those who have been transplanted, and are often driven by Epstein-Barr virus (EBV)...
7.
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study
Zaroui A, Kharoubi M, Gounot R, Oghina S, Degoutte C, Bezard M, et al.
ESC Heart Fail
. 2024 Mar;
11(3):1707-1719.
PMID: 38444090
Aims: Predicting mortality in severe AL cardiac amyloidosis is challenging due to elevated biomarker levels and limited thresholds for stratifying severe cardiac damage. Methods And Results: This prospective, observational, cohort...
8.
Poullot E, Milowich D, Lemonnier F, Bisig B, Robe C, Pelletier L, et al.
Histopathology
. 2023 Nov;
84(3):556-564.
PMID: 37988271
Aims: Follicular helper T-cell (TFH) lymphoma of the angioimmunoblastic-type (AITL), one of the most prevalent T-cell lymphomas, typically encompasses proliferation of high endothelial venules and Epstein-Barr virus-positive immunoblasts, but neither...
9.
Albenque G, Bezard M, Kharoubi M, Odouard S, Lunati A, Poullot E, et al.
Amyloid
. 2023 Jun;
30(4):407-415.
PMID: 37377439
Background: Hereditary transthyretin (ATTRv) p.Val142Ile (V122I) mutation is the most common inherited cause of cardiac amyloidosis and little is known about the phenotype and outcome of the rare homozygotic genotype....
10.
Le Goff E, Blanc-Durand P, Roulin L, Lafont C, Loyaux R, MBoumbae D, et al.
Br J Haematol
. 2023 Apr;
202(1):54-64.
PMID: 37038217
Approximately 20%-50% of patients with large B-cell lymphoma (LBCL) experience poor outcomes. We aimed to evaluate the combined prognostic value of circulating tumour DNA (ctDNA) and total metabolic tumour volume...